1-8 of 8
Authors: David W. Haas
Save search
Sort by
Journal Article
EDITOR'S CHOICE

Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population

PDF
Rulan Griesel and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3110–3117, https://doi.org/10.1093/jac/dkac290
Published: 29 August 2022
Journal Article

Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353

PDF
Amesika N Nyaku and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1376–1380, https://doi.org/10.1093/jac/dky564
Published: 18 January 2019
Journal Article

Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites

PDF
Eric H Decloedt and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 699–709, https://doi.org/10.1093/jac/dky481
Published: 10 December 2018
Journal Article

Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individuals

PDF
Tailah Bernardo de Almeida and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 9, September 2018, Pages 2460–2467, https://doi.org/10.1093/jac/dky190
Published: 03 June 2018
Journal Article

Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

PDF
Jose R. Castillo-Mancilla and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 6, June 2016, Pages 1609–1618, https://doi.org/10.1093/jac/dkw005
Published: 17 February 2016
Journal Article

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes Get access

PDF
David W. Haas and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 8, August 2014, Pages 2175–2182, https://doi.org/10.1093/jac/dku110
Published: 11 April 2014
Journal Article

Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, Haiti Get access

PDF
David W. Haas and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 8, August 2014, Pages 2187–2190, https://doi.org/10.1093/jac/dku088
Published: 02 April 2014
Journal Article

Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent Get access

PDF
David W. Haas and Thad Bonczar
Journal of Antimicrobial Chemotherapy, Volume 38, Issue 2, August 1996, Pages 293–299, https://doi.org/10.1093/jac/38.2.293
Published: 01 August 1996